Close
0
You have no items in your order cart.
Search
Filters

Librela - 10mg - 2 vials

Librela is the first-of-its-kind veterinary medicine that contains bedinvetmab, a monoclonal antibody that binds to Nerve Growth Factor (NGF), a key player in OA pain and in doing so reduces pain. It functions like naturally occurring antibodies, with minimal involvement of the liver or kidneys in its metabolism and elimination from the body; bedinvetmab also produces minimal gastrointestinal (GI) impact. After one injection of Librela, dogs with osteoarthritis exhibited increased mobility and decreased pain.
Availability: In stock
SKU: 160794
Product tags
Customers who bought this item also bought

VS Comprehensive Diagnostic Profile Rotor Test

157164
Provides complete chemistry for VETSCAN analyser, with electrolyte analysis for pre-anaesthetic, general health, ill patients, geriatric, and wellness testing.

Terramycin Aerosol - 150ml

103940
Terramycin Aerosol Spray is indicated for the treatment and control of topical infections caused by, or associated with, organisms sensitive to the action of oxytetracycline. Use in treatment for foot rot and scald in sheep and digital dermatitis in cattle.

Withdrawal: MEAT AND OFFAL: Nil,
MILK: Nil.

Active ingredient: Oxytetracycline

VS Prep Profile II rotor Test

157144
The Prep Profile II is ideal for basic health screening for pre-anesthetic evaluation and testing minimal values for baselines of young, healthy patients or a recheck profile for some disease states. The Prep Profile II provides important information for renal, hepatic, and diabetic patients that are being hospitalized, monitored, or undergoing long-term treatment.

Librela - 5mg - 2 vials

160784
Librela is the first-of-its-kind veterinary medicine that contains bedinvetmab, a monoclonal antibody that binds to Nerve Growth Factor (NGF), a key player in OA pain and in doing so reduces pain. It functions like naturally occurring antibodies, with minimal involvement of the liver or kidneys in its metabolism and elimination from the body; bedinvetmab also produces minimal gastrointestinal (GI) impact. After one injection of Librela, dogs with osteoarthritis exhibited increased mobility and decreased pain.